HALEIGH MISTRY: Open Payments
NPI 1316361512 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$795 in 15 payments from 6 companies in 2025. Trend: 2023 $1,432 · 2024 $5,495 · 2025 $795
Food & beverage: $753Travel & lodging: $42
| Company | Payments | Amount |
|---|---|---|
| RECORDATI_RARE_DISEASES_INC. | 6 | $227 |
| Genmab U.S., Inc. | 3 | $208 |
| ADC THERAPEUTICS AMERICA, INC. | 3 | $198 |
| Janssen Scientific Affairs, LLC | 1 | $91 |
| JAZZ PHARMACEUTICALS INC. | 1 | $39 |
| ABBVIE INC. | 1 | $32 |
Products named: Epkinly, SYLVANT, ZYNLONTA, DARZALEX, RYLAZE.
Industry payments across TX — which companies pay providers there.
